Scientific Advisory Board

The Scientific Advisory Board, chaired by Dr. David Rattner, comprised of leading research clinicians and scientists, contributed to the selection of the Frantz Medical Ventures portfolio companies. All of the SAB members have experience in biotechnology and medical devices, offering clinical, research and business perspectives.

David W. Rattner, M.D., Chair

• Chief, Division of General and Gastrointestinal Surgery,  Massachusetts General Hospital.
• Director, Minimally Invasive Surgery, Harvard Medical School.
• Program Director, Operating Room of the Future, Center for Innovative Minimally Invasive Therapy.
• President, Society of American Gastrointestinal and Endoscopic Surgeons

Antonio M. Gotto, Jr., M.D.

• Dean and Provost, Weill Medical College, Cornell University
• Former President, American Heart Association
• Member, Board of Directors, Medtronic, Inc.

Adrian Hobden, Ph.D.

• President, Myriad Pharmaceuticals
• Former Director, Glaxo-Wellcome

James B. Wyngaarden, M.D.

• Former Director, National Institutes of Health
• Former Associate Director, Office of Science Policy, Executive Office of the President
• Vice Chancellor for Health Affairs, Duke University (retired)

Scientific Advisory Board previous members

Isador Lieberman, M.D., M.B.A.

• Director, Center for Minimally Invasive Surgery,
• Director, Center for Advanced Skills Training, and
• Department of Orthopedics, Cleveland Clinic

Marc S. Penn, M.D., Ph.D., FACC

• Medical Director, Coronary Intensive Care Unit,
• Director, Experimental Animal Laboratory, and
• Associate Director, Cardiovascular Medicine Training Program, Cleveland Clinic

Patrick Whitlow, M.D.

• Director, Interventional Cardiology, and
• Departments of Vascular Surgery and Molecular Cardiology, Cleveland Clinic